Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
Moreira, M A
Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis. [electronic resource] - Acta neurologica Scandinavica Aug 2006 - 109-13 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0001-6314
10.1111/j.1600-0404.2006.00629.x doi
Adult
Anti-Inflammatory Agents--pharmacology
Biomarkers--blood
Chemokine CCL2--blood
Chemokine CXCL10
Chemokines, CXC--blood
Chemotaxis, Leukocyte--immunology
Controlled Clinical Trials as Topic
Down-Regulation--drug effects
Female
Humans
Male
Methylprednisolone--pharmacology
Middle Aged
Multiple Sclerosis, Relapsing-Remitting--drug therapy
Predictive Value of Tests
Treatment Outcome
Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis. [electronic resource] - Acta neurologica Scandinavica Aug 2006 - 109-13 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0001-6314
10.1111/j.1600-0404.2006.00629.x doi
Adult
Anti-Inflammatory Agents--pharmacology
Biomarkers--blood
Chemokine CCL2--blood
Chemokine CXCL10
Chemokines, CXC--blood
Chemotaxis, Leukocyte--immunology
Controlled Clinical Trials as Topic
Down-Regulation--drug effects
Female
Humans
Male
Methylprednisolone--pharmacology
Middle Aged
Multiple Sclerosis, Relapsing-Remitting--drug therapy
Predictive Value of Tests
Treatment Outcome